CARSGEN-B 02171Hong Kong Stock Exchange

11.6303.57%( -0.430 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
CARSGEN-B (02171) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2021-06-18
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG1996C1006
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)147.36M86/112
Net Profit (Last FY)-114.76M66/125
ROE (Last FY)-12.49%68/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Zonghai LI Executive Director
Huamao WANG Executive Director
Hua JIANG Executive Director
Ronggang XIE Non-Executive Director
Huaqing GUO Non-Executive Director
Guangmei YAN Independent Non-Executive Director
Wen ZHOU Independent Non-Executive Director
Xiangke ZHAO Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-09-24.

About this page

This page shows CARSGEN-B (02171) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.